Skip to main content

Table 2 Tumour characteristics

From: Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Tumour characteristics

Number of patients (N = 149)

Tumour presentation

 Primary

127 (85.23%)

 Recurrent

22 (14.76%)

Number of the tumour

 Single

97 (65.1%)

 Multiple

52 (34.8%)

Size of the tumour

 < 3 cm

104 (69.79%)

 > 3 cm

45 (30.2%)

T stage after first TURBT

 T0

11

 Ta low grade

19

 Ta high grade

50

 T1

44

 CIS

25

T stage after second TURBT

 T0

51

 Ta low grade

09

 Ta high grade

24

 T1

18

 CIS

21

 Biopsy not required

26

Planned BCG course

 1 year

105 (70.4%)

 3 year

44 (29.5%)

Course completed

96 (64.4%)

Course interrupted

53 (35.5%)